He oversaw the creation of Alberta's Commission on Learning and implemented many of its recommendations, including the reduction of provincial class sizes.
[6] On 22 March 2006, shortly after announcing his resignation from his ministerial position following a directive from Premier Ralph Klein to all ministers running to replace him, Oberg was removed from the Progressive Conservative caucus after making comments at a Strathmore-Brooks Constituency Association annual general meeting urging the membership to vote their conscience in a crucial leadership vote at the March 2006 AGM of the party.
[11] Oberg's allegations of scandal on front runner Jim Dinning in the summer of 2006 appeared to have had a negative effect on his campaign.
He stepped down as president and CEO the following day to avoid any conflict over a medical doctor being involved with such a high tech company, but said he would remain an advisor.
He cited the Conservative government's decision to abolish the multiple health districts in Alberta and replace them with an Edmonton-based super board, and the recently announced deficit budget, the fourth in as many years, as his reason for the switch.
[19] He is chief executive officer of MYND Life Sciences Inc., a Canadian company that has developed biomarker test technology which will be used in a clinical trial of psilocybin-assisted psychotherapy.